Metastasis suppressors genes in cancer.

The major problem for cancer patients is metastasis of the cancer from the primary tumor to secondary sites. Metastasis is the process by which tumor cells disseminate from the primary tumor, migrate through the basement membrane, survive in the circulatory system, invade into a secondary site, and start to proliferate. In the past, research had concentrated on the biology, taking more of a global view instead of a molecular view. More recently, the focus has been determining the molecular underpinnings, looking at genes that induce or inhibit metastasis. Metastasis suppressors, by definition, inhibit metastasis at any step of the metastatic cascade without blocking primary tumor growth. The expanding list of metastasis suppressors exist with every cellular compartment and have been shown to work by regulating signaling pathways that inhibit proliferation, cell migration and growth at the secondary site. Still, the biochemical basis of their inhibition is not completely known. Here we review the known metastasis suppressors and summarize the suspected mechanisms by which they inhibit metastasis.

[1]  P. Steeg Metastasis suppressors alter the signal transduction of cancer cells , 2003, Nature Reviews Cancer.

[2]  Victoria Bolós,et al.  Notch signaling in development and cancer. , 2007, Endocrine reviews.

[3]  T. Mashimo,et al.  Activation of the tumor metastasis suppressor gene, KAI1, by etoposide is mediated by p53 and c-Jun genes. , 2000, Biochemical and biophysical research communications.

[4]  B. Weissman,et al.  Suppression of MDA-MB-435 breast carcinoma cell metastasis following the introduction of human chromosome 11. , 1996, Cancer research.

[5]  R. Khokha Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. , 1994, Journal of the National Cancer Institute.

[6]  V. Robinson,et al.  MKK4 and metastasis suppression: A marriage of signal transduction and metastasis research , 2004, Clinical & Experimental Metastasis.

[7]  S. Thorgeirsson,et al.  Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. , 1998, Cancer research.

[8]  D. Welch,et al.  Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone. , 2006, Biochemical and biophysical research communications.

[9]  R. Biondi,et al.  Inhibition of nucleoside diphosphate kinase activity by in vitro phosphorylation by protein kinase CK2 Differential phosphorylation of NDP kinases in HeLa cells in culture , 1996, FEBS letters.

[10]  E. Ruoslahti Specialization of tumour vasculature , 2002, Nature Reviews Cancer.

[11]  G. Bevilacqua,et al.  High level of messenger RNA for BRMS1 in primary breast carcinomas is associated with poor prognosis , 2007, International journal of cancer.

[12]  P. Steeg,et al.  Nm23/Nucleoside Diphosphate Kinase in Human Cancers , 2000, Journal of bioenergetics and biomembranes.

[13]  B. O'dowd,et al.  Identification of a Molecular Target of Psychosine and Its Role in Globoid Cell Formation , 2001, The Journal of cell biology.

[14]  P. Kleihues,et al.  Loss of DCC expression and glioma progression. , 1997, Cancer research.

[15]  B. Su,et al.  SSeCKS metastasis-suppressing activity in MatLyLu prostate cancer cells correlates with vascular endothelial growth factor inhibition. , 2006, Cancer research.

[16]  G. Casey,et al.  Breast Cancer Metastasis Suppressor 1 Inhibits Gene Expression by Targeting Nuclear Factor-κB Activity , 2005 .

[17]  Chrisostomos Prodromou,et al.  Regulation of Hsp90 ATPase activity by tetratricopeptide repeat (TPR)‐domain co‐chaperones , 1999, The EMBO journal.

[18]  K. Pacak,et al.  Downregulation of metastasis suppressor genes in malignant pheochromocytoma , 2005, International journal of cancer.

[19]  E. Odintsova,et al.  Tetraspanin CD82 regulates compartmentalisation and ligand-induced dimerization of EGFR , 2003, Journal of Cell Science.

[20]  J E Talmadge,et al.  Evidence for a novel gene associated with low tumor metastatic potential. , 1988, Journal of the National Cancer Institute.

[21]  J. Keaney,et al.  EGF receptor-dependent JNK activation is involved in arsenite-induced p21Cip1/Waf1 upregulation and endothelial apoptosis. , 2005, American journal of physiology. Heart and circulatory physiology.

[22]  P. Meltzer,et al.  Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2. , 2007, Cancer research.

[23]  D. Welch,et al.  Breast cancer metastasis suppressor 1: Update , 2004, Clinical & Experimental Metastasis.

[24]  S. Thorgeirsson,et al.  Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells , 2004, Oncogene.

[25]  D. Welch,et al.  Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication. , 2001, Cancer research.

[26]  Kedar S Vaidya,et al.  Expression of the Breast Cancer Metastasis Suppressor 1 (BRMS1) maintains in vitro chemosensitivity of breast cancer cells. , 2009, Cancer letters.

[27]  Yong Pan,et al.  Evidence of MKK4 pro-oncogenic activity in breast and pancreatic tumors , 2004, Oncogene.

[28]  D. Morrison,et al.  Nm23-H1 Metastasis Suppressor Phosphorylation of Kinase Suppressor of Ras via a Histidine Protein Kinase Pathway* , 2002, The Journal of Biological Chemistry.

[29]  K. Arden,et al.  Functional genomic comparison of lineage-related human bladder cancer cell lines with differing tumorigenic and metastatic potentials by spectral karyotyping, comparative genomic hybridization, and a novel method of positional expression profiling. , 2002, Cancer research.

[30]  C. Miranti,et al.  Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases , 2006, Oncogene.

[31]  A. Logan,et al.  Angiogenesis , 1993, The Lancet.

[32]  Gabriele Schackert,et al.  CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme. , 2007, Carcinogenesis.

[33]  P. Jackson,et al.  Down-regulation of KAI1/CD82 protein expression in oral cancer correlates with reduced disease free survival and overall patient survival. , 2004, Cancer letters.

[34]  W. Cole,et al.  Technique and results of isolation of cancer cells from the circulating blood. , 1958, A.M.A. archives of surgery.

[35]  Héctor Peinado,et al.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.

[36]  J. Hamada,et al.  Gelsolin functions as a metasatsis suppressor in B16‐BL6 mouse melanoma cells and requirement of the carboxyl‐terminus for its effect , 2001, International journal of cancer.

[37]  W. Weis,et al.  Re-solving the Cadherin-Catenin-Actin Conundrum* , 2006, Journal of Biological Chemistry.

[38]  F. Berditchevski,et al.  Function of α3β1–Tetraspanin Protein Complexes in Tumor Cell Invasion. Evidence for the Role of the Complexes in Production of Matrix Metalloproteinase 2 (Mmp-2) , 1999, The Journal of cell biology.

[39]  P. Herrlich,et al.  The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. , 1993, Cancer research.

[40]  J. Barrett,et al.  KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. , 1995, Science.

[41]  M. Hemler Tetraspanin functions and associated microdomains , 2005, Nature Reviews Molecular Cell Biology.

[42]  C. Underhill,et al.  CD44: the hyaluronan receptor. , 1992, Journal of cell science.

[43]  N. Shimada,et al.  Evidence for complex formation between GTP binding protein(Gs) and membrane-associated nucleoside diphosphate kinase. , 1990, Biochemical and biophysical research communications.

[44]  K. Kim,et al.  KAI1 COOH-Terminal Interacting Tetraspanin (KITENIN), a Member of the Tetraspanin Family, Interacts with KAI1, a Tumor Metastasis Suppressor, and Enhances Metastasis of Cancer , 2004, Cancer Research.

[45]  Lei Liu,et al.  EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells. , 2003, Cancer research.

[46]  J. Bravo,et al.  Proteomics-based strategy to delineate the molecular mechanisms of the metastasis suppressor gene BRMS1. , 2007, Journal of proteome research.

[47]  D. Welch,et al.  Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13. , 2000, Cancer research.

[48]  Kathleen R. Cho,et al.  Identification of a chromosome 18q gene that is altered in colorectal cancers. , 1990, Science.

[49]  Bin Zhou,et al.  The Palmitoylation of Metastasis Suppressor KAI1/CD82 Is Important for Its Motility- and Invasiveness-Inhibitory Activity , 2004, Cancer Research.

[50]  Andrew J. Ewald,et al.  Matrix metalloproteinases and the regulation of tissue remodelling , 2007, Nature Reviews Molecular Cell Biology.

[51]  M. Rosner,et al.  Raf Kinase Inhibitory Protein Regulates Raf-1 but Not B-Raf Kinase Activation* , 2005, Journal of Biological Chemistry.

[52]  S. Ramaswamy,et al.  Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.

[53]  C. Moskaluk,et al.  RhoGDI2 is an invasion and metastasis suppressor gene in human cancer. , 2002, Cancer research.

[54]  A. Iizuka,et al.  Induction of KAI-1 expression in metastatic cancer cells by phorbol esters. , 2000, Cancer letters.

[55]  P. Waterhouse,et al.  Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. , 1992, Journal of the National Cancer Institute.

[56]  A. Montag,et al.  Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma. , 2002, Cancer research.

[57]  Ying Jiang,et al.  Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer. , 2007, Journal of the National Cancer Institute.

[58]  H. Frierson,et al.  Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia , 2007, Oncogene.

[59]  M. Yáñez-Mó,et al.  Regulatory role of tetraspanin CD9 in tumor-endothelial cell interaction during transendothelial invasion of melanoma cells. , 2001, Blood.

[60]  O. Nishimura,et al.  Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor , 2001, Nature.

[61]  S. Thorgeirsson,et al.  DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity , 2003, Oncogene.

[62]  L. Freedman,et al.  Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP. , 2003, Cancer research.

[63]  S. Goodison,et al.  The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. , 2005, Cancer research.

[64]  D. Boyd,et al.  KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa Balpha -induced block of p65/p50 nuclear translocation. , 2001, The Journal of biological chemistry.

[65]  K Satyamoorthy,et al.  N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. , 2001, Cancer research.

[66]  B. Weimer,et al.  Microarray analysis reveals potential mechanisms of BRMS1-mediated metastasis suppression , 2007, Clinical & Experimental Metastasis.

[67]  Nils Cordes,et al.  Signalling via integrins: implications for cell survival and anticancer strategies. , 2007, Biochimica et biophysica acta.

[68]  D. Welch Do we need to redefine a cancer metastasis and staging definitions? , 2006, Breast disease.

[69]  R. Davis,et al.  Role of mitogen-activated protein kinase kinase 4 in cancer , 2007, Oncogene.

[70]  C. López-Otín,et al.  Emerging roles of proteases in tumour suppression , 2007, Nature Reviews Cancer.

[71]  J. Thiery Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[72]  J. Figge,et al.  Decreased levels of CD44 protein and mRNA in prostate carcinoma: Correlation with tumor grade and ploidy , 1996, Cancer.

[73]  M. Oshimura,et al.  Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11. , 1992, Cancer research.

[74]  Alicia Zhou,et al.  Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers , 2007, Proceedings of the National Academy of Sciences.

[75]  M. Cristofanilli,et al.  Manipulating the chemokine‐chemokine receptor network to treat cancer , 2007, Cancer.

[76]  Xiu-fen Lei,et al.  Inhibition of pulmonary and skeletal metastasis by a transforming growth factor-beta type I receptor kinase inhibitor. , 2006, Cancer research.

[77]  C. Kahn,et al.  Regulation of growth and tumorigenicity of breast cancer cells by the low molecular weight GTPase Rad and nm23. , 2001, Cancer research.

[78]  L. Liotta,et al.  Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm3-transfected melanoma cells , 1991, Cell.

[79]  Karin Oien,et al.  Reduction of Raf-1 Kinase Inhibitor Protein Expression Correlates with Breast Cancer Metastasis , 2005, Clinical Cancer Research.

[80]  C. D. dos Remedios,et al.  Actin binding proteins: regulation of cytoskeletal microfilaments. , 2003, Physiological reviews.

[81]  W. Ellis,et al.  Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[82]  H. Aburatani,et al.  Overexpression of cadherins suppresses pulmonary metastasis of osteosarcoma in vivo , 2003, International journal of cancer.

[83]  M. Toyota,et al.  Epigenetic Regulation of the KAI1 Metastasis Suppressor Gene in Human Prostate Cancer Cell Lines , 2001, Japanese journal of cancer research : Gann.

[84]  Y. Okada,et al.  TIMP-2 Promotes Activation of Progelatinase A by Membrane-type 1 Matrix Metalloproteinase Immobilized on Agarose Beads* , 1998, The Journal of Biological Chemistry.

[85]  D. Lambeth,et al.  The Human Nm23/Nucleoside Diphosphate Kinases , 2000, Journal of bioenergetics and biomembranes.

[86]  Hee June Choi,et al.  Transcriptional regulation of a metastasis suppressor gene by Tip60 and β-catenin complexes , 2005, Nature.

[87]  K. Tanaka,et al.  Loss of expression of the DCC gene during progression of colorectal carcinomas in familial adenomatous polyposis and non-familial adenomatous polyposis patients. , 1992, Cancer research.

[88]  C. Sheehan,et al.  Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer. , 2004, Annals of diagnostic pathology.

[89]  S. Eccles,et al.  Metastasis: recent discoveries and novel treatment strategies , 2007, The Lancet.

[90]  I. Hilgert,et al.  Association of four antigens of the tetraspans family (CD37, CD53, TAPA-1, and R2/C33) with MHC class II glycoproteins , 2004, Immunogenetics.

[91]  Hyun Seok Song,et al.  SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier , 2003, Nature Medicine.

[92]  J. Barrett,et al.  Loss of KAI1 expression in the progression of colorectal cancer. , 1999, Cancer research.

[93]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[94]  Jeffrey W. Clark,et al.  Lessons from phase III clinical trials on anti-VEGF therapy for cancer , 2006, Nature Clinical Practice Oncology.

[95]  S. Steinberg,et al.  Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer. , 2005, Journal of the National Cancer Institute.

[96]  C. Boucheix,et al.  CD19 Is Linked to the Integrin-associated Tetraspans CD9, CD81, and CD82* , 1998, The Journal of Biological Chemistry.

[97]  J. Vassy,et al.  Cytoskeletal association of the A and B nucleoside diphosphate kinases of interphasic but not mitotic human carcinoma cell lines: specific nuclear localization of the B subunit. , 1999, Experimental cell research.

[98]  K. Miura,et al.  The Drg-1 gene suppresses tumor metastasis in prostate cancer. , 2003, Cancer research.

[99]  A. Alessandrini,et al.  Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1. , 2002, Experimental cell research.

[100]  P. Waterhouse,et al.  Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. , 1989, Science.

[101]  The KISS1 metastasis suppressor: mechanistic insights and clinical utility. , 2006, Frontiers in bioscience : a journal and virtual library.

[102]  Deqin Ma,et al.  Potential roles of 3′-5′exonuclease activity of NM23-H1 in DNA repair and malignant progression , 2006, Journal of bioenergetics and biomembranes.

[103]  P. Friedl,et al.  Collective cell migration in morphogenesis and cancer. , 2004, The International journal of developmental biology.

[104]  G. Casey,et al.  Identification of metastasis-associated proteins through protein analysis of metastatic MDA-MB-435 and metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells , 2004, Clinical & Experimental Metastasis.

[105]  Kedar S Vaidya,et al.  Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy. , 2007, Journal of the National Cancer Institute.

[106]  M. Yamazaki,et al.  Drug-dependent cellular cytotoxicity mediated by polymorphonuclear leukocytes. , 1985, Japanese journal of cancer research : Gann.

[107]  L. Liotta,et al.  A Drosophila gene that is homologous to a mammalian gene associated with tumor metastasis codes for a nucleoside diphosphate kinase , 1990, Cell.

[108]  I. Gelman,et al.  Mitogen-induced, FAK-dependent tyrosine phosphorylation of the SSeCKS scaffolding protein. , 2002, Experimental cell research.

[109]  C. Welter,et al.  Glyceraldehyde-3-phosphate Dehydrogenase and Nm23-H1/Nucleoside Diphosphate Kinase A , 1998, The Journal of Biological Chemistry.

[110]  J. Becker,et al.  Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation. , 2003, Cancer research.

[111]  R. Silverman,et al.  Caspase-dependent apoptosis by 2',5'-oligoadenylate activation of RNase L is enhanced by IFN-beta. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[112]  Dan Theodorescu,et al.  Reduced Expression of Metastasis Suppressor RhoGDI2 Is Associated with Decreased Survival for Patients with Bladder Cancer , 2004, Clinical Cancer Research.

[113]  J. Szöllősi,et al.  Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY. , 1996, Journal of immunology.

[114]  G. Casey,et al.  Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-κB activation , 2007, Molecular Cancer.

[115]  M. Hung,et al.  KAI1 metastasis suppressor gene is frequently down-regulated in cervical carcinoma. , 2001, The American journal of pathology.

[116]  Deqin Ma,et al.  The Metastasis Suppressor NM23-H1 Possesses 3′-5′ Exonuclease Activity* , 2004, Journal of Biological Chemistry.

[117]  J. Barrett,et al.  Correlation between reduction of metastasis in the MDA‐MB‐435 model system and increased expression of the Kai‐1 protein , 1998, Molecular carcinogenesis.

[118]  三宅 智 Point mutations and allelic deletion of tumor suppressor gene DCC in human esophageal squamous cell carcinomas and their relation to metastasis , 1995 .

[119]  T. Koyanagi,et al.  Gelsolin: a candidate for suppressor of human bladder cancer. , 1995, Cancer research.

[120]  A. Al-Mehdi,et al.  Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis , 2000, Nature Medicine.

[121]  P. Houghton,et al.  Potentiation of neuroblastoma metastasis by loss of caspase-8 , 2006, Nature.

[122]  S. Aaronson,et al.  Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. , 1998, Cancer research.

[123]  S. Brewster,et al.  Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma. , 1994, The Journal of urology.

[124]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[125]  R. Samant Breast Cancer Metastasis-Suppressor 1 , 2008, Definitions.

[126]  Wim H. M. Saris,et al.  Proceedings of the American Association for Cancer Research. , 2001 .

[127]  E. Bruyneel,et al.  Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis , 2007, Oncogene.

[128]  Y. DeClerck,et al.  Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) Binds to the Catalytic Domain of the Cell Surface Receptor, Membrane Type 1-Matrix Metalloproteinase 1 (MT1-MMP)* , 1998, The Journal of Biological Chemistry.

[129]  P. Steeg,et al.  Site-directed Mutation of Nm23-H1 , 1997, The Journal of Biological Chemistry.

[130]  M. Popoff,et al.  Rho GTPases link cytoskeletal rearrangements and activation processes induced via the tetraspanin CD82 in T lymphocytes. , 2002, Journal of cell science.

[131]  I. Fidler,et al.  Genetic control of cancer metastasis. , 1990, Journal of the National Cancer Institute.

[132]  C J Rhodes,et al.  Interaction of the Ras-related protein associated with diabetes rad and the putative tumor metastasis suppressor NM23 provides a novel mechanism of GTPase regulation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[133]  H. Ford,et al.  Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. , 2000, Cancer research.

[134]  N. Christensen,et al.  Analysis of mechanisms underlying BRMS1 suppression of metastasis , 2004, Clinical & Experimental Metastasis.

[135]  G. Sonenshein,et al.  Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells. , 2007, Cancer research.

[136]  D. Stupack,et al.  Does integrin-mediated cell death confer tissue tropism in metastasis? , 2006, Cancer research.

[137]  Gillian Murphy,et al.  The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase A , 1998, The Journal of Biological Chemistry.

[138]  E. Robertson,et al.  Regulation of Matrix Metalloproteinase 9 Expression by Epstein-Barr Virus Nuclear Antigen 3C and the Suppressor of Metastasis Nm23-H1 , 2005, Journal of Virology.

[139]  M. Fukayama,et al.  Molecular genetics for clinical management of colorectal carcinoma. 17p, 18q, and 22q loss of heterozygosity and decreased DCC expression are correlated with the metastatic potential , 1994, Cancer.

[140]  Joseph C. Shope,et al.  Metastasis suppression by breast cancer metastasis suppressor 1 involves reduction of phosphoinositide signaling in MDA-MB-435 breast carcinoma cells. , 2005, Cancer research.

[141]  C. Chitnis,et al.  A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. , 1993, Science.

[142]  B. Weissman,et al.  Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity. , 1994, Oncogene.

[143]  A. Strongin,et al.  Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase , 1995, The Journal of Biological Chemistry.

[144]  D. Theodorescu,et al.  The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines , 2004, Clinical & Experimental Metastasis.

[145]  H. Mehdorn,et al.  Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases , 2005, Journal of Cancer Research and Clinical Oncology.

[146]  G. Casey,et al.  Osteopontin Knockdown Suppresses Tumorigenicity of Human Metastatic Breast Carcinoma, MDA-MB-435 , 2006, Clinical & Experimental Metastasis.

[147]  D. Huo,et al.  The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma. , 2006, Cancer research.

[148]  O. Witte,et al.  Differential proton sensitivity of related G protein-coupled receptors T cell death-associated gene 8 and G2A expressed in immune cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[149]  R. Poulsom,et al.  E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. , 1993, The American journal of pathology.

[150]  M. Murakami,et al.  Critical function of T cell death-associated gene 8 in glucocorticoid-induced thymocyte apoptosis. , 2003, International immunology.

[151]  M. Hung,et al.  Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma. , 2000, Gynecologic oncology.

[152]  Matthew J. Craig,et al.  CCL2 (Monocyte Chemoattractant Protein-1) in cancer bone metastases , 2007, Cancer and Metastasis Reviews.

[153]  Rakesh K Jain,et al.  Molecular regulation of vessel maturation , 2003, Nature Medicine.

[154]  B. Aggarwal,et al.  RKIP Sensitizes Prostate and Breast Cancer Cells to Drug-induced Apoptosis* , 2004, Journal of Biological Chemistry.

[155]  P. Steeg,et al.  MMTV-associated transcription factor binding sites increase nm23-H1 metastasis suppressor gene expression in human breast carcinoma cell lines , 2004, Clinical & Experimental Metastasis.

[156]  G. Bismuth,et al.  Tetraspanin CD82 controls the association of cholesterol-dependent microdomains with the actin cytoskeleton in T lymphocytes: relevance to co-stimulation , 2004, Journal of Cell Science.

[157]  G. Bepler,et al.  Suppression of lung tumor formation by the regulatory subunit of ribonucleotide reductase. , 2006, Cancer research.

[158]  B. Weissman,et al.  KAI1, a putative marker for metastatic potential in human breast cancer. , 1997, Cancer letters.

[159]  P. Steeg,et al.  Inhibition of signal transduction by the nm23 metastasis suppressor: Possible mechanisms , 2004, Clinical & Experimental Metastasis.

[160]  Kedar S Vaidya,et al.  BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process. , 2008, The American journal of pathology.

[161]  P. Steeg,et al.  Nm23 and tumour metastasis: basic and translational advances. , 1998, Biochemical Society symposium.

[162]  S. Hirohashi,et al.  Concordant p53 and DCC alterations and allelic losses on chromosomes 13q and 14q associated with liver metastases of colorectal carcinoma , 1993, International journal of cancer.

[163]  H. Hamada,et al.  Overexpression of CD82 on human T cells enhances LFA‐1 / ICAM‐1‐mediated cell‐cell adhesion: functional association between CD82 and LFA‐1 in T cell activation , 1999, European journal of immunology.

[164]  Philip Smith,et al.  Breast Cancer Metastasis Suppressor 1 Functions as a Corepressor by Enhancing Histone Deacetylase 1-Mediated Deacetylation of RelA/p65 and Promoting Apoptosis , 2006, Molecular and Cellular Biology.

[165]  J. Workman,et al.  Breast Cancer Metastasis Suppressor 1 (BRMS1) Forms Complexes with Retinoblastoma-binding Protein 1 (RBP1) and the mSin3 Histone Deacetylase Complex and Represses Transcription* , 2004, Journal of Biological Chemistry.

[166]  M. Takata,et al.  Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23. , 2001, Cancer research.

[167]  F. Berditchevski,et al.  Transmembrane-4 superfamily proteins CD81 (TAPA-1), CD82, CD63, and CD53 specifically associated with integrin alpha 4 beta 1 (CD49d/CD29). , 1996, Journal of immunology.

[168]  W. Stadler,et al.  Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17. , 1999, Cancer research.

[169]  H. Frierson,et al.  Endothelin axis is a target of the lung metastasis suppressor gene RhoGDI2. , 2005, Cancer research.

[170]  F. Huang,et al.  Lysophosphatidylcholine impairs endothelial barrier function through the G protein-coupled receptor GPR4. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[171]  Stuart A. Aaronson,et al.  Exogenous Expression of N-Cadherin in Breast Cancer Cells Induces Cell Migration, Invasion, and Metastasis , 2000, The Journal of cell biology.

[172]  John D. Potter,et al.  Morphogens, morphostats, microarchitecture and malignancy , 2007, Nature Reviews Cancer.

[173]  Loss of DCC expression in neuroblastoma is associated with disease dissemination. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[174]  Arul M. Chinnaiyan,et al.  Selection and cloning of poly(rC)-binding protein 2 and Raf kinase inhibitor protein RNA activators of 2′,5′-oligoadenylate synthetase from prostate cancer cells , 2006, Nucleic acids research.

[175]  W. Dinjens,et al.  A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[176]  D. Welch,et al.  Metastasis-suppressed C8161 melanoma cells arrest in lung but fail to proliferate , 2004, Clinical & Experimental Metastasis.

[177]  A. Lin,et al.  Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7. , 2005, Cancer research.

[178]  P. Jackson,et al.  KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells , 2005, Oncogene.

[179]  Xu-wen Liu,et al.  Novel functions of TIMPs in cell signaling , 2006, Cancer and Metastasis Reviews.

[180]  G. Casey,et al.  Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity. , 2005, Cancer research.

[181]  Jing Qiao,et al.  GPR4 plays a critical role in endothelial cell function and mediates the effects of sphingosylphosphorylcholine , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[182]  T. Toyama,et al.  Reduced Expression of the Breast Cancer Metastasis Suppressor 1 mRNA Is Correlated with Poor Progress in Breast Cancer , 2006, Clinical Cancer Research.

[183]  S. Thorgeirsson,et al.  DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas , 2004, Oncogene.

[184]  D. Tarin,et al.  Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? , 2005, Cancer research.

[185]  F. Itoh,et al.  Decreased expression of DCC mRNA in human colorectal cancers , 1993, International journal of cancer.

[186]  D. Ross,et al.  Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma , 2007, Modern Pathology.

[187]  P. Steeg,et al.  A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential. , 1993, The Journal of biological chemistry.

[188]  L. Matrisian,et al.  Measurement of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Blood and Tissues: Clinical and Experimental Applications , 1999, Annals of the New York Academy of Sciences.

[189]  P. Steeg,et al.  Inhibition of cell motility after nm23 transfection of human and murine tumor cells. , 1993, Cancer research.

[190]  T. Choueiri,et al.  Loss of Breast Cancer Metastasis Suppressor 1 Protein Expression Predicts Reduced Disease-Free Survival in Subsets of Breast Cancer Patients , 2006, Clinical Cancer Research.

[191]  J. Risteli,et al.  Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[192]  M. Kuwano,et al.  Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. , 2006, Cancer research.